nVerses Capital’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
nVerses Capital's JAZZ Position: Q3 2026 in Review
nVerses Capital sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2026, closing a stake of 1,141 shares — an estimated $275K sold.
nVerses Capital first reported a position in JAZZ in Q3 2024 and held it in 2 quarters. The position peaked at $290K in Q3 2024. 670 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.
- nVerses Capital reported no remaining Jazz Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- nVerses Capital sold 1,141 Jazz Pharmaceuticals shares in Q3 2026, an estimated $275K.
- nVerses Capital first reported a position in Jazz Pharmaceuticals in Q3 2024 and held it in 2 quarters.
- nVerses Capital's Jazz Pharmaceuticals position peaked at $290K in Q3 2024.
- 670 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.
Based on nVerses Capital's 13F filing for Q3 2026.